Thromboembolism – Page 9 – Communicable Diseases Research

Biomarkers for Thrombosis in COVID-19: A Role for High Sensitivity Troponin-I and Immature Platelet Fraction?

Conference abstract

Published on 2021-11-232022-10-05
Journal: Blood [Category] 바이오마커,

Factors Associated With Risk of Postdischarge Thrombosis in Patients With COVID-19

Research

Published on 2021-11-222022-10-29
Journal: JAMA Network Open [Category] COVID-19, MERS,

[키워드] 95% CI Admission age Analysis anticoagulation arterial thromboembolic event association benefit bleeding C-reactive protein classification cohort study coronary syndrome COVID-19 COVID-19 infection D-dimer dimerized discharge enrolled evaluate event events exposure Factor finding greater Henry Ford high-risk patient hospital Hospitalization identify Importance incidence IQR measure median men New objective occurred Odds ratio participant Patient patients hospitalized patients with COVID-19 peak D-dimer Point positive prescription reduced Relevance Result revision risk SARS-CoV-2 test setting supported symptomatic System the mean therapeutic anticoagulation therapy Thromboembolism Thromboprophylaxis thrombosis thrombotic venous thromboembolic Venous Thromboembolism was performed with COVID-19
[DOI] 10.1001/jamanetworkopen.2021.35397 PMC 바로가기 [Article Type] Research

Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials

Review

Published on 2021-11-182022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Extended minimally invasive autopsy: Technical improvements for the investigation of cardiopulmonary events in COVID-19

확장된 최소 침습적 부검: COVID-19의 심폐 사건 조사를 위한 기술 개선

Original Article

Published on 2021-11-172022-09-10
Journal: Clinics [Category] MERS, SARS, 치료기술,

COVID-19 Associated Coagulopathy Resulting in Cerebral Venous Thrombosis and Pulmonary Embolism

Internal Medicine

Published on 2021-11-152022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] acute respiratory syndrome Blood cerebral cerebral venous thrombosis cvt changes Coagulopathy coronavirus Coronavirus disease 2019 COVID 19 COVID-19 CTPA D-dimer Dexamethasone diagnosed with COVID-19 Diagnosis discharged disease dose DVT Embolism English Evidence Fever HDU head headache Hemorrhagic high dependency unit independent risk factor infective Like lingular lung maintain Myocardial infarction neurological Neurological symptoms nystagmus patchy pulmonary pulmonary embolism (PE) raised reported SARS-CoV-2 Severe COVID-19 Infection severity stroke therapeutic Thromboembolic event Thromboembolism thrombosis Thrombus Tocilizumab Treatment venous Venous thrombosis
[DOI] 10.7759/cureus.19602 PMC 바로가기 [Article Type] Internal Medicine

Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials

Research

Published on 2021-11-132022-10-29
Journal: Thrombosis Journal [Category] COVID-19,

Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications

COVID-19에서 혈소판 염증 및 내피 손상의 병원성 근거: 현재 연구 결과 및 치료적 시사점

Review

Published on 2021-11-082022-09-10
Journal: International Journal of Molecular Sciences [Category] MERS, SARS, 유전자 메커니즘, 치료제,

[키워드] activities acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition Atypical B cell responses Basis cardiovascular risk factors cause caused coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 current dry cough dysregulated dysregulated immune responses Endothelial dysfunction endothelial injury exacerbated Fever finding global pandemic high mortality highlight immune evasion immune responses Inflammation interferon interferon signaling interstitial pneumonia knowledge leads mechanisms morbidity Most patients multiple organ failure Organ failure Pathogenesis pathogenesis of COVID-19 pathogenic patients platelet activation platelet hyperactivation public health respiratory respiratory distress resulting SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus severe cases suppression symptoms of COVID-19 syndrome T cell therapeutic strategy Therapeutics Thromboembolism Thromboinflammation thrombosis
[DOI] 10.3390/ijms222112081 PMC 바로가기 [Article Type] Review

A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection

Review Article

Published on 2021-11-062022-10-29
Journal: Journal of Clinical and Translational Research [Category] COVID-19,

[키워드] Acute coronary syndrome acute phase acute respiratory syndrome added Admission age benefit cardiac disease cardiovascular cardiovascular disease Case report caused co-morbid conditions Comorbidities Complication conducted coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 antibody test COVID-19 infection COVID-19 patient develop diagnosed died Echocardiogram Google Scholar had more had no higher risk identify incidence Infection lack left ventricular thrombus management Mild symptom mortality rate MOST Myocardial infarction occur outcome Patient Precaution Prevent Relevance risk factor Risk factors SARS- CoV-2 Severe acute respiratory syndrome the patient Thromboembolism thrombosis Thrombus Venous Thromboembolism ventricular Web of Science
PMC 바로가기 [Article Type] Review Article

Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial

Randomized Controlled Trial

Published on 2021-11-022022-10-05
Journal: JAMA [Category] 임상,

[키워드] 95% CI adaptive all-cause mortality Analysis anticipated Anticoagulant antiplatelet antithrombotic therapy Aspirin benefit bleeding event Cardiopulmonary clinical Clinical outcome clinically conducted COVID-19 diagnosis to randomization did not reduce dose double-blind Effect Efficacy end point Enrollment event rate Final finding Follow-up glomerular filtration rate greater groups Hospitalization Hospitalized initiated Inpatient Intervention median age median time monitoring board Myocardial infarction occurred outcome Outpatient participant Patient Placebo placebo-controlled trial Platelet prevention primary end point Prophylactic random allocation randomization Randomized randomized patient receive reduce required risk risk difference STABLE stroke symptomatic the placebo group therapeutic therapy Thromboembolism Treatment Trial trial medication venous with COVID-19 women
[DOI] 10.1001/jama.2021.17272 PMC 바로가기 [Article Type] Randomized Controlled Trial

Abdominal Computed Tomography Angiography and Venography in Evaluation of Hemorrhagic and Thrombotic lesions in Hospitalized COVID-19 patients

입원한 COVID-19 환자의 출혈성 및 혈전성 병변 평가에서 복부 컴퓨터 단층 촬영 혈관 조영술 및 정맥 조영술

Observational Study

Published on 2021-11-012022-09-11
Journal: Clinical imaging [Category] SARS, 임상, 치료기술,

[키워드] abdomen Abdomen and pelvis abdominal pain acute abdominal pain Admission age angiography Arterial thrombosis bowel Care Complication complications Computed tomography Computed tomography angiography Computed tomography venography coronavirus disease Coronavirus disease 2019 Course COVID-19 patient CTA diagnosed early diagnosis evaluated event hematoma hemoglobin hemorrhage Hemorrhagic highlight Hospitalization hospitalized patient hospitalized patients ICU Infarct intensive care intensive care unit intramuscular involved Ischemia lesion maintain men observational study one patient Patient patients pelvis performed positive radiologist Radiologists Rectus sheath required retrospective SARS-CoV-2 suspicion tested thromboembolic thromboembolic complication thromboembolic complications Thromboembolic events Thromboembolism thrombosis thrombotic tomography treated venography Venous thrombosis were recorded with COVID-19 women
[DOI] 10.1016/j.clinimag.2021.04.002 PMC 바로가기 [Article Type] Observational Study